Terms: = Lung cancer AND PRF1, P14222, PFP, P1, MGC65093, HPLH2, FLH2, ENSG00000180644, 5551 AND Treatment
67 results:
1. CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
Qu J; Wu B; Chen L; Wen Z; Fang L; Zheng J; Shen Q; Heng J; Zhou J; Zhou J
J Exp Clin Cancer Res; 2024 May; 43(1):134. PubMed ID: 38698468
[TBL] [Abstract] [Full Text] [Related]
2. LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer.
Liu Y; Tang R; Cao Y; Wu N; Qin Q; Chen Y; Wei X; Ren J; Sun Y; Zhou H; Zhou Y; Li P
J Nanobiotechnology; 2024 Apr; 22(1):209. PubMed ID: 38664830
[TBL] [Abstract] [Full Text] [Related]
3. Interpersonal Values of Patients Participating in Phase II-III Clinical Trials: Implications for Clinical Trial Representativeness.
Gouveia R; Cruz VT; Antão J; Almeida L
Pharmaceut Med; 2023 Jul; 37(4):319-329. PubMed ID: 37249821
[TBL] [Abstract] [Full Text] [Related]
4. Phase-transition nanodroplets with immunomodulatory capabilities for potentiating mild magnetic hyperthermia to inhibit tumour proliferation and metastasis.
Qin Q; Zhou Y; Li P; Liu Y; Deng R; Tang R; Wu N; Wan L; Ye M; Zhou H; Wang Z
J Nanobiotechnology; 2023 Apr; 21(1):131. PubMed ID: 37069614
[TBL] [Abstract] [Full Text] [Related]
5. MiR-513a-3p promotes radiation-induced apoptosis of human lung cells by inhibiting glutathione S-transferase P1.
Zhou H; Yao B; Qian L; Hu H; Duan Q
Pharmazie; 2022 Apr; 77(3):121-124. PubMed ID: 35459441
[TBL] [Abstract] [Full Text] [Related]
6. Personalized functional profiling using
Kim H; El-Khoury V; Schulte N; Zhan T; Betge J; Cousin L; Felli E; Pessaux P; Ogier A; Opitz O; Ku B; Ebert MP; Kwon YJ
Cancer Biol Ther; 2022 Dec; 23(1):96-102. PubMed ID: 35193475
[TBL] [Abstract] [Full Text] [Related]
7. Impact of glutathione S transferases P1 (Ile105Val) variants on the risk of GSTp, phosphorylated c-Jun kinase, and P53 phenotypic expression and their implications on overall survival outcomes in non-small cell lung cancer patients treated with chemotherapy.
Pathak AK; Husain N; Shukla S; Pandey RK; Kant S; Bala L
Mutat Res; 2022; 824():111775. PubMed ID: 35124341
[TBL] [Abstract] [Full Text] [Related]
8. Can assessment of disease burden and quality of life based on mobility level in patients with end-stage cancer provide an insight into unmet needs? An exploratory cross-sectional study.
Bahar-Ozdemir Y; Kaya S; Babacan NA; Al T; Albayrak E; Coskun N; Akyuz G
Physiother Theory Pract; 2023 Jun; 39(6):1141-1151. PubMed ID: 35100940
[TBL] [Abstract] [Full Text] [Related]
9. GSTP1
Walia HK; Singh N; Sharma S
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S739-S752. PubMed ID: 34780261
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study.
Fukuhara T; Saito H; Furuya N; Watanabe K; Sugawara S; Iwasawa S; Tsunezuka Y; Yamaguchi O; Okada PM; Yoshimori K; Nakachi I; Gemma PA; Azuma K; Kurimoto F; Tsubata Y; Fujita Y; Nagashima H; Asai G; Watanabe S; Miyazaki M; Hagiwara PK; Nukiwa PT; Morita PS; Kobayashi PK; Maemondo PM
EBioMedicine; 2020 Jul; 57():102861. PubMed ID: 32629391
[TBL] [Abstract] [Full Text] [Related]
11. Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16).
Metaxas Y; Früh M; Eboulet EI; Grosso F; Pless M; Zucali PA; Ceresoli GL; Mark M; Schneider M; Maconi A; Perrino M; Biaggi-Rudolf C; Froesch P; Schmid S; Waibel C; Appenzeller C; Rauch D; von Moos R;
Ann Oncol; 2020 Apr; 31(4):495-500. PubMed ID: 32085891
[TBL] [Abstract] [Full Text] [Related]
12. Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction.
Tripathi SK; Rengasamy KRR; Biswal BK
Arch Pharm Res; 2020 Feb; 43(2):242-256. PubMed ID: 32034669
[TBL] [Abstract] [Full Text] [Related]
13. Enhancing doxorubicin anticancer activity with a novel polymeric platform photoreleasing nitric oxide.
Sodano F; Cavanagh RJ; Pearce AK; Lazzarato L; Rolando B; Fraix A; Abelha TF; Vasey CE; Alexander C; Taresco V; Sortino S
Biomater Sci; 2020 Mar; 8(5):1329-1344. PubMed ID: 31912808
[TBL] [Abstract] [Full Text] [Related]
14. Impaired Cytolytic Activity and Loss of Clonal Neoantigens in Elderly Patients With lung Adenocarcinoma.
Gong Z; Jia Q; Chen J; Diao X; Gao J; Wang X; Zhu B
J Thorac Oncol; 2019 May; 14(5):857-866. PubMed ID: 30768970
[TBL] [Abstract] [Full Text] [Related]
15. [IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].
Mignard X; Antoine M; Moro-Sibilot D; Dayen C; Mennecier B; Gervais R; Amour E; Milleron B; Morin F; Zalcman G; Wislez M
Rev Mal Respir; 2018 Nov; 35(9):983-988. PubMed ID: 30243521
[TBL] [Abstract] [Full Text] [Related]
16. Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis.
Duruisseaux M; Martínez-Cardús A; Calleja-Cervantes ME; Moran S; Castro de Moura M; Davalos V; Piñeyro D; Sanchez-Cespedes M; Girard N; Brevet M; Giroux-Leprieur E; Dumenil C; Pradotto M; Bironzo P; Capelletto E; Novello S; Cortot A; Copin MC; Karachaliou N; Gonzalez-Cao M; Peralta S; Montuenga LM; Gil-Bazo I; Baraibar I; Lozano MD; Varela M; Ruffinelli JC; Palmero R; Nadal E; Moran T; Perez L; Ramos I; Xiao Q; Fernandez AF; Fraga MF; Gut M; Gut I; Teixidó C; Vilariño N; Prat A; Reguart N; Benito A; Garrido P; Barragan I; Emile JF; Rosell R; Brambilla E; Esteller M
Lancet Respir Med; 2018 Oct; 6(10):771-781. PubMed ID: 30100403
[TBL] [Abstract] [Full Text] [Related]
17. Targeting RNA polymerase I transcription machinery in cancer cells by a novel monofunctional platinum-based agent.
Zhang ZL; Zhao CL; Chen Q; Xu K; Qiao X; Xu JY
Eur J Med Chem; 2018 Jul; 155():434-444. PubMed ID: 29908438
[TBL] [Abstract] [Full Text] [Related]
18. A Bowman-Birk type chymotrypsin inhibitor peptide from the amphibian, Hylarana erythraea.
Zhang L; Chen X; Wu Y; Zhou M; Ma C; Xi X; Chen T; Walker B; Shaw C; Wang L
Sci Rep; 2018 Apr; 8(1):5851. PubMed ID: 29643444
[TBL] [Abstract] [Full Text] [Related]
19. Energy landscape of a GSTP1 polymorph linked with cytological function decay in response to chemical stressors.
Basharat Z; Yasmin A
Gene; 2017 Apr; 609():19-27. PubMed ID: 28153749
[TBL] [Abstract] [Full Text] [Related]
20. The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.
De Luca A; Carpanese D; Rapanotti MC; Viguria TM; Forgione MA; Rotili D; Fulci C; Iorio E; Quintieri L; Chimenti S; Bianchi L; Rosato A; Caccuri AM
Oncotarget; 2017 Feb; 8(9):15520-15538. PubMed ID: 28107182
[TBL] [Abstract] [Full Text] [Related]
[Next]
